Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| HERBALIFE LTD.HLF · Entity 4842 | Director · Executive Chairman | February 25, 2026 | March 04, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
HERBALIFE LTD.
Report date February 25, 2026 · Filed March 04, 2026 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 887,415 |
Reported balance
After 2026-02-25 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2026-02-25 · Grant · Acquired 72,689 · Balance 887,415 F1: Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. Amended and Restated 2023 Stock Incentive Plan (the "Plan"). These RSUs will vest in two installments, 50% on February 25, 2027, and 50% on February 25, 2028, subject to continued service through such date. |
| Stock Appreciation RightsSEC Table II · derivative / convertible security · Conversion / exercise price $19.26 · Expires 2036-02-25 | Direct | 399,619 |
Reported balance
After 2026-02-25 transaction · row 2
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 2 · 2026-02-25 · Grant · Acquired 399,619 · Balance 399,619 F2: This amendment is being filed solely to correct the exercise price, which was previously reported as $10.51. No other information in the original Form 4 has been changed. F3: Consists of stock appreciation rights ("SARs") granted under the Plan. These SARs will vest in two installments, 50% on February 25, 2027, and 50% on February 25, 2028, subject to continued service through such date. |
Filing footnotes · ownership attribution and instrument terms
F1: Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. Amended and Restated 2023 Stock Incentive Plan (the "Plan"). These RSUs will vest in two installments, 50% on February 25, 2027, and 50% on February 25, 2028, subject to continued service through such date.
F2: This amendment is being filed solely to correct the exercise price, which was previously reported as $10.51. No other information in the original Form 4 has been changed.
F3: Consists of stock appreciation rights ("SARs") granted under the Plan. These SARs will vest in two installments, 50% on February 25, 2027, and 50% on February 25, 2028, subject to continued service through such date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 25, 2026 Filed Feb 28, 2026 01:33 UTC | HERBALIFE LTD. HLF · Entity 4842 | GrantStock Appreciation Rights · Derivative | 399,619 | $0.00 Strike: $10.51 | $0.00 |
DisclosureSEC source: 0001213900-26-021910 · ownership.xml · derivative · entry 2 JOHNSON MICHAEL · CIK 0001311173 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 399,619 Underlying: Common Stock · 399,619 shares Expires 2036-02-25 F2 · derivative.exercise_date: Consists of stock appreciation rights ("SARs") granted under the Plan. These SARs will vest in two installments, 50% on February 25, 2027, and 50% on February 25, 2028, subject to continued service through such date. Read SEC document |
| February 25, 2026 Filed Feb 28, 2026 01:33 UTC | HERBALIFE LTD. HLF · Entity 4842 | GrantCommon Stock | 72,689 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-021910 · ownership.xml · nonDerivative · entry 1 JOHNSON MICHAEL · CIK 0001311173 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 887,415 F1 · shares: Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. Amended and Restated 2023 Stock Incentive Plan (the "Plan"). These RSUs will vest in two installments, 50% on February 25, 2027, and 50% on February 25, 2028, subject to continued service through such date. Read SEC document |
| February 25, 2026 Filed Mar 4, 2026 02:26 UTC Amendment | HERBALIFE LTD. HLF · Entity 4842 | GrantStock Appreciation Rights · Derivative | 399,619 | $0.00 Strike: $19.26 | $0.00 |
DisclosureSEC source: 0001213900-26-023335 · ownership.xml · derivative · entry 2 JOHNSON MICHAEL · CIK 0001311173 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 399,619 Underlying: Common Stock · 399,619 shares Expires 2036-02-25 F2 · derivative.exercise_price: This amendment is being filed solely to correct the exercise price, which was previously reported as $10.51. No other information in the original Form 4 has been changed. F3 · derivative.exercise_date: Consists of stock appreciation rights ("SARs") granted under the Plan. These SARs will vest in two installments, 50% on February 25, 2027, and 50% on February 25, 2028, subject to continued service through such date. Read SEC document |
| February 25, 2026 Filed Mar 4, 2026 02:26 UTC Amendment | HERBALIFE LTD. HLF · Entity 4842 | GrantCommon Stock | 72,689 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-023335 · ownership.xml · nonDerivative · entry 1 JOHNSON MICHAEL · CIK 0001311173 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 887,415 F1 · shares: Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. Amended and Restated 2023 Stock Incentive Plan (the "Plan"). These RSUs will vest in two installments, 50% on February 25, 2027, and 50% on February 25, 2028, subject to continued service through such date. Read SEC document |
| August 29, 2025 Filed Sep 3, 2025 23:00 UTC | HERBALIFE LTD. HLF · Entity 4842 | Tax withholdingCommon Stock | 125,849 | $9.78 | $1,230,803.22 |
DisclosureSEC source: 0001213900-25-084204 · ownership.xml · nonDerivative · entry 1 JOHNSON MICHAEL · CIK 0001311173 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 814,726 F1 · shares: Represents shares withheld to satisfy tax obligations due in connection with the vesting of Restricted Stock Units previously granted to the Reporting Person on February 16, 2024. Read SEC document |
| February 21, 2025 Filed Feb 26, 2025 01:12 UTC | HERBALIFE LTD. HLF · Entity 4842 | GrantStock Appreciation Rights · Derivative | 442,477 | $0.00 Strike: $8.31 | $0.00 |
DisclosureSEC source: 0000950170-25-027109 · ownership.xml · derivative · entry 1 JOHNSON MICHAEL · CIK 0001311173 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 442,477 Underlying: Common Stock · 442,477 shares Expires 2035-02-21 F1 · derivative.exercise_date: Consists of stock appreciation rights ("SARs") granted under the Herbalife Ltd. Amended and Restated 2023 Stock Incentive Plan. These SARs will vest in two installments, 50% on February 21, 2026 and 50% on the date of the Company's Annual General Meeting of Shareholders in 2026 , subject to certain conditions of his service as CEO and/or member of the Issuer's Board of Directors. Read SEC document |
| February 16, 2025 Filed Feb 19, 2025 21:44 UTC | HERBALIFE LTD. HLF · Entity 4842 | Tax withholdingCommon Stock | 125,600 | $5.62 | $705,872.00 |
DisclosureSEC source: 0000950170-25-023271 · ownership.xml · nonDerivative · entry 1 JOHNSON MICHAEL · CIK 0001311173 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 940,575 F1 · shares: Represents shares withheld to satisfy tax obligations due in connection with the vesting of Restricted Stock Units previously granted to the Reporting Person on February 16, 2024. Read SEC document |
| December 22, 2024 Filed Dec 26, 2024 21:34 UTC | HERBALIFE LTD. HLF · Entity 4842 | Tax withholdingCommon Stock | 87,682 | $6.48 | $568,179.36 |
DisclosureSEC source: 0000950170-24-140441 · ownership.xml · nonDerivative · entry 1 JOHNSON MICHAEL · CIK 0001311173 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,066,175 F1 · shares: Represents shares withheld to satisfy tax obligations due in connection with the vesting of Restricted Stock Units previously granted to the Reporting Person on December 22, 2022. Read SEC document |
| February 16, 2024 Filed Feb 21, 2024 22:44 UTC | HERBALIFE LTD. HLF · Entity 4842 | GrantStock Appreciation Rights · Derivative | 982,800 | $0.00 Strike: $8.07 | $0.00 |
DisclosureSEC source: 0000950170-24-018170 · ownership.xml · derivative · entry 5 JOHNSON MICHAEL · CIK 0001311173 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 982,800 Underlying: Common Stock · 982,800 shares Expires 2034-02-16 F5 · derivative.exercise_date: Consists of stock appreciation rights ("SARs") granted under the Herbalife Ltd. 2023 Stock Incentive Plan. These SARs will vest in two installments, 50% on February 16, 2025, and 50% on the earlier of January 3, 2026, or the date on which a new non-interim Chief Executive Officer has been appointed by the Board, subject to certain conditions of his service as CEO and/or member of the Board. Provided that, in no instance shall any portion of the SAR vest prior to February 16, 2025. Read SEC document |
| February 16, 2024 Filed Feb 21, 2024 22:44 UTC | HERBALIFE LTD. HLF · Entity 4842 | Tax withholdingCommon Stock | 30,351 | $8.07 | $244,932.57 |
DisclosureSEC source: 0000950170-24-018170 · ownership.xml · nonDerivative · entry 4 JOHNSON MICHAEL · CIK 0001311173 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,153,857 F4 · shares: Represents shares withheld to satisfy tax obligations due in connection with the vesting of RSUs previously granted to the Reporting Person on February 16, 2024. Read SEC document |
| February 16, 2024 Filed Feb 21, 2024 22:44 UTC | HERBALIFE LTD. HLF · Entity 4842 | GrantCommon Stock | 84,839 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-018170 · ownership.xml · nonDerivative · entry 3 JOHNSON MICHAEL · CIK 0001311173 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,184,208 F3 · shares: Consists of RSUs fully vested at the time of grant. Read SEC document |
| February 16, 2024 Filed Feb 21, 2024 22:44 UTC | HERBALIFE LTD. HLF · Entity 4842 | GrantCommon Stock | 495,662 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-018170 · ownership.xml · nonDerivative · entry 2 JOHNSON MICHAEL · CIK 0001311173 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,099,369 F2 · shares: Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. 2023 Stock Incentive Plan. These RSUs will vest in two installments, 50% on February 16, 2025, and 50% on the earlier of January 3, 2026, or the date on which a new non-interim Chief Executive Officer has been appointed by the Issuer's Board of Directors (the "Board"), subject to certain conditions of his service as CEO and/or member of the Board. Provided that, in no instance shall any portion of the RSU vest prior to February 16, 2025. Read SEC document |
| February 16, 2024 Filed Feb 21, 2024 22:44 UTC | HERBALIFE LTD. HLF · Entity 4842 | PurchaseCommon Stock | 61,725 | $8.07 | $498,299.75 |
DisclosureSEC source: 0000950170-24-018170 · ownership.xml · nonDerivative · entry 1 JOHNSON MICHAEL · CIK 0001311173 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 603,707 F1 · price: This transaction represents multiple open market purchases. The range of prices for such transactions is $7.84 to $8.20. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a shareholder of the Issuer, full information regarding the number of shares purchased at each price. Read SEC document |
| December 22, 2023 Filed Dec 27, 2023 23:55 UTC | HERBALIFE LTD. HLF · Entity 4842 | Tax withholdingCommon Stock | 79,100 | $15.07 | $1,192,037.00 |
DisclosureSEC source: 0001209191-23-059828 · doc4.xml · nonDerivative · entry 1 JOHNSON MICHAEL · CIK 0001311173 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 541,982 F1 · shares: Represents shares withheld to satisfy tax obligations due in connection with the vesting of restricted stock units previously granted to the Reporting Person on December 22, 2022. Read SEC document |
| December 22, 2022 Filed Dec 27, 2022 21:28 UTC | HERBALIFE LTD. HLF · Entity 4842 | GrantStock Appreciation Rights · Derivative | 783,699 | $0.00 Strike: $14.45 | $0.00 |
DisclosureSEC source: 0001209191-22-062708 · doc4.xml · derivative · entry 2 JOHNSON MICHAEL · CIK 0001311173 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 783,699 Underlying: Common Stock · 783,699 shares Expires 2032-12-22 F2 · derivative.exercise_date: On December 22, 2022, the reporting person was granted 783,699 SARs. These SARs will vest 100% on December 22, 2024, subject to certain terms and conditions of his continuing service as CEO and/or member of the Board. Read SEC document |
| December 22, 2022 Filed Dec 27, 2022 21:28 UTC | HERBALIFE LTD. HLF · Entity 4842 | GrantCommon Stock | 346,020 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-062708 · doc4.xml · nonDerivative · entry 1 JOHNSON MICHAEL · CIK 0001311173 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 621,082 F1 · shares: Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. 2014 Stock Incentive Plan. The RSUs will vest 50% on December 22, 2023, and December 22, 2024, subject to certain terms and conditions of his continuing service as CEO and/or member of the Board. Read SEC document |
| December 09, 2022 Filed Dec 13, 2022 21:17 UTC | HERBALIFE LTD. HLF · Entity 4842 | PurchaseCommon Stock | 19,675 | $12.69 | $249,646.24 |
DisclosureSEC source: 0001209191-22-060920 · doc4.xml · nonDerivative · entry 1 JOHNSON MICHAEL · CIK 0001311173 · Director · Chairman & interim CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 275,062 F1 · price: This transaction was executed in multiple trades at prices ranging from $12.4525 to $12.75. The price reported reflects the weighted average purchase price of $12.6885. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 12, 2022 Filed May 12, 2022 21:19 UTC | HERBALIFE LTD. HLF · Entity 4842 | PurchaseCommon Stock | 5,840 | $22.85 | $133,444.00 |
DisclosureSEC source: 0001209191-22-028605 · doc4.xml · nonDerivative · entry 1 JOHNSON MICHAEL · CIK 0001311173 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255,387 F1 · price: This transaction was executed in multiple trades at prices ranging from $22.835 to $22.870. The price reported reflects the weighted average purchase price of $22.85. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 05, 2022 Filed May 9, 2022 20:18 UTC | HERBALIFE LTD. HLF · Entity 4842 | GrantCommon Stock | 5,387 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-027834 · doc4.xml · nonDerivative · entry 1 JOHNSON MICHAEL · CIK 0001311173 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 249,547 F1 · shares: Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. 2014 Stock Incentive Plan. The RSUs will vest 100% on April 15, 2023, subject to continued service on the Issuer's Board of Directors through such date. Read SEC document |
| February 21, 2020 Filed Feb 24, 2020 22:01 UTC | HERBALIFE LTD. HLF · Entity 4842 | GrantStock Appreciation Rights · Derivative | 105,932 | $0.00 Strike: $28.60 | $0.00 |
DisclosureSEC source: 0001209191-20-012041 · doc4.xml · derivative · entry 1 JOHNSON MICHAEL · CIK 0001311173 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,552 Underlying: Common Stock · 105,932 shares Expires 2027-02-27 F1 · shares: On February 27, 2017, the Reporting Person was granted an award of 176,552 PSARs (number adjusted to reflect the Issuer's 2-for-1 stock split on May 14, 2018). The amount and timing of the vesting of these PSARs was dependent upon achievement by the Issuer of certain performance criteria for each of fiscal 2017, 2018 and 2019. With the satisfaction of the performance criteria for fiscal 2019, 105,932 PSARs will vest on February 27, 2020, subject to continued service through each applicable date. Read SEC document |
| May 06, 2019 Filed May 8, 2019 23:17 UTC | HERBALIFE LTD. HLF · Entity 4842 | GrantCommon Stock | 2,689 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-028352 · doc4.xml · nonDerivative · entry 1 JOHNSON MICHAEL · CIK 0001311173 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,411,022 F1 · shares: Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. 2014 Stock Incentive Plan. The RSUs will vest 100% on April 15, 2020, subject to continued service on the Issuer's Board of Directors through such date. F2 · balance_after: Amount reflected corrects the balance due to prior administrative error. Read SEC document |
| April 15, 2019 Filed Apr 18, 2019 01:21 UTC | HERBALIFE LTD. HLF · Entity 4842 | Tax withholdingCommon Stock | 827 | $52.25 | $43,210.75 |
DisclosureSEC source: 0001209191-19-025196 · doc4.xml · nonDerivative · entry 1 JOHNSON MICHAEL · CIK 0001311173 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,478,331 F1 · shares: Units withheld to satisfy the withholding tax obligations due in connection with the vesting of restricted stock units previously granted to the Reporting Person on May 7, 2018. Read SEC document |
| February 22, 2019 Filed Feb 25, 2019 22:26 UTC | HERBALIFE LTD. HLF · Entity 4842 | GrantStock Appreciation Rights · Derivative | 35,310 | $0.00 Strike: $28.60 | $0.00 |
DisclosureSEC source: 0001209191-19-013092 · doc4.xml · derivative · entry 2 JOHNSON MICHAEL · CIK 0001311173 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,620 Underlying: Common Stock · 35,310 shares Expires 2027-02-27 F2 · shares: On February 27, 2017, the Reporting Person was granted an award of 176,552 PSARs, which number reflects the Issuer's 2-for-1 stock split on May 14, 2018. The amount and timing of the vesting of these PSARs is dependent upon achievement by the Issuer of certain performance criteria for each of fiscal 2017, 2018 and 2019. As the performance criteria for 2018 has been satisfied, 35,310 PSARs will vest on February 27, 2019, subject to continued service through each applicable date. Read SEC document |
| February 22, 2019 Filed Feb 25, 2019 22:26 UTC | HERBALIFE LTD. HLF · Entity 4842 | GrantStock Appreciation Rights · Derivative | 201,544 | $0.00 Strike: $31.26 | $0.00 |
DisclosureSEC source: 0001209191-19-013092 · doc4.xml · derivative · entry 1 JOHNSON MICHAEL · CIK 0001311173 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 335,908 Underlying: Common Stock · 201,544 shares Expires 2026-05-09 F1 · shares: On May 9, 2016, the Reporting Person was granted an award of 335,908 performance stock appreciation rights ("PSARs"), which number reflects the Issuer's 2-for-1 stock split on May 14, 2018. The amount and timing of the vesting of these PSARs is dependent upon achievement by the Issuer of certain performance criteria for each of fiscal 2016, 2017 and 2018. As the performance criteria for 2018 has been satisfied, 201,544 PSARs will vest on May 9, 2019, subject to continued service through each applicable date. Read SEC document |
| June 07, 2018 Filed Jun 11, 2018 20:17 UTC | HERBALIFE LTD. HLF · Entity 4842 | Exercise / conversionStock Appreciation Rights · Derivative | 815,660 | $0.00 Strike: $15.22 | $0.00 |
DisclosureSEC source: 0001209191-18-036928 · doc4.xml · derivative · entry 10 JOHNSON MICHAEL · CIK 0001311173 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 815,660 shares Expires 2025-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.underlying_shares: These SARS were previously reported as covering 407,830 shares at an exercise price of $30.44 per share, but were adjusted to reflect the stock split that occurred on May 14, 2018. Read SEC document |
| June 07, 2018 Filed Jun 11, 2018 20:17 UTC | HERBALIFE LTD. HLF · Entity 4842 | Exercise / conversionStock Appreciation Rights · Derivative | 384,910 | $0.00 Strike: $29.99 | $0.00 |
DisclosureSEC source: 0001209191-18-036928 · doc4.xml · derivative · entry 9 JOHNSON MICHAEL · CIK 0001311173 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 384,910 shares Expires 2024-04-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.underlying_shares: These SARS were previously reported as covering 192,455 shares at an exercise price of $59.98 per share, but were adjusted to reflect the stock split that occurred on May 14, 2018. Read SEC document |
| June 07, 2018 Filed Jun 11, 2018 20:17 UTC | HERBALIFE LTD. HLF · Entity 4842 | Tax withholdingCommon Stock | 304,064 | $52.13 | $15,850,856.32 |
DisclosureSEC source: 0001209191-18-036928 · doc4.xml · nonDerivative · entry 6 JOHNSON MICHAEL · CIK 0001311173 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,479,158 F3 · kind: The reporting person received 273,452 shares of common stock upon the net exercise of 815,660 SARS. The reporting person forfeited 238,144 shares of common stock underlying such SARS in payment of the exercise price and 304,064 shares of common stock underlying such SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on June 7, 2018 of $52.13. Read SEC document |
| June 07, 2018 Filed Jun 11, 2018 20:17 UTC | HERBALIFE LTD. HLF · Entity 4842 | Disposition to issuerCommon Stock | 238,144 | $52.13 | $12,414,446.72 |
DisclosureSEC source: 0001209191-18-036928 · doc4.xml · nonDerivative · entry 5 JOHNSON MICHAEL · CIK 0001311173 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,783,222 F3 · kind: The reporting person received 273,452 shares of common stock upon the net exercise of 815,660 SARS. The reporting person forfeited 238,144 shares of common stock underlying such SARS in payment of the exercise price and 304,064 shares of common stock underlying such SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on June 7, 2018 of $52.13. Read SEC document |
| June 07, 2018 Filed Jun 11, 2018 20:17 UTC | HERBALIFE LTD. HLF · Entity 4842 | Exercise / conversionCommon Stock | 815,660 | $15.22 | $12,414,345.20 |
DisclosureSEC source: 0001209191-18-036928 · doc4.xml · nonDerivative · entry 4 JOHNSON MICHAEL · CIK 0001311173 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,021,366 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 07, 2018 Filed Jun 11, 2018 20:17 UTC | HERBALIFE LTD. HLF · Entity 4842 | Tax withholdingCommon Stock | 86,070 | $52.13 | $4,486,829.10 |
DisclosureSEC source: 0001209191-18-036928 · doc4.xml · nonDerivative · entry 3 JOHNSON MICHAEL · CIK 0001311173 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,205,706 F2 · kind: The reporting person received 77,402 shares of common stock upon the net exercise of 384,910 stock appreciation rights ("SARS"). The reporting person forfeited 221,438 shares of common stock underlying such SARS in payment of the exercise price and 86,070 shares of common stock underlying such SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on June 7, 2018 of $52.13. Read SEC document |
| June 07, 2018 Filed Jun 11, 2018 20:17 UTC | HERBALIFE LTD. HLF · Entity 4842 | Disposition to issuerCommon Stock | 221,438 | $52.13 | $11,543,562.94 |
DisclosureSEC source: 0001209191-18-036928 · doc4.xml · nonDerivative · entry 2 JOHNSON MICHAEL · CIK 0001311173 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,291,776 F2 · kind: The reporting person received 77,402 shares of common stock upon the net exercise of 384,910 stock appreciation rights ("SARS"). The reporting person forfeited 221,438 shares of common stock underlying such SARS in payment of the exercise price and 86,070 shares of common stock underlying such SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on June 7, 2018 of $52.13. Read SEC document |
| June 07, 2018 Filed Jun 11, 2018 20:17 UTC | HERBALIFE LTD. HLF · Entity 4842 | Exercise / conversionCommon Stock | 384,910 | $29.99 | $11,543,450.90 |
DisclosureSEC source: 0001209191-18-036928 · doc4.xml · nonDerivative · entry 1 JOHNSON MICHAEL · CIK 0001311173 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,513,214 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: On May 14, 2018, the common stock of Herbalife Nutrition Ltd. split 2-for-1, resulting in the reporting person's ownership of 2,064,152 additional shares of common stock. Read SEC document |
| May 07, 2018 Filed May 9, 2018 21:17 UTC | HERBALIFE LTD. HLF · Entity 4842 | GrantCommon Stock | 1,195 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-028931 · doc4.xml · nonDerivative · entry 1 JOHNSON MICHAEL · CIK 0001311173 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,064,152 F1 · kind: Consists of Restricted Stock Units ("RSU") under the Herbalife Nutrition Ltd. 2014 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of Herbalife Ltd. common stock on vesting. This award will vest 100% on April 15, 2019. Read SEC document |
| February 22, 2018 Filed Feb 27, 2018 02:17 UTC | HERBALIFE LTD. HLF · Entity 4842 | GrantStock Appreciation Rights · Derivative | 17,655 | $0.00 Strike: $57.19 | $0.00 |
DisclosureSEC source: 0001209191-18-013689 · doc4.xml · derivative · entry 3 JOHNSON MICHAEL · CIK 0001311173 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,655 Underlying: Common Stock · 17,655 shares Expires 2027-02-27 F3 · kind: On February 27, 2017, the reporting person was granted an award of 88,276 SARs. The amount and timing of the vesting of these SARs is dependent upon the achievement by the Company of certain performance criteria for each of fiscal 2017, 2018 and 2019. The performance criteria for 2017 was met, resulting in 17,655 SARs which will vest on February 27, 2018. Read SEC document |
| February 22, 2018 Filed Feb 27, 2018 02:17 UTC | HERBALIFE LTD. HLF · Entity 4842 | GrantStock Appreciation Rights · Derivative | 33,591 | $0.00 Strike: $47.80 | $0.00 |
DisclosureSEC source: 0001209191-18-013689 · doc4.xml · derivative · entry 2 JOHNSON MICHAEL · CIK 0001311173 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,182 Underlying: Common Stock · 33,591 shares Expires 2026-05-09 F2 · kind: On May 9, 2016, the reporting person was granted an award of 167,954 SARs. The amount and timing of the vesting of these SARs is dependent upon the achievement by the Company of certain performance criteria for each of fiscal 2016, 2017 and 2018. The performance criteria for 2017 was met, resulting in 33,951 SARs which will vest on May 9, 2018. Read SEC document |
| February 22, 2018 Filed Feb 27, 2018 02:17 UTC | HERBALIFE LTD. HLF · Entity 4842 | GrantStock Appreciation Rights · Derivative | 244,698 | $0.00 Strike: $30.44 | $0.00 |
DisclosureSEC source: 0001209191-18-013689 · doc4.xml · derivative · entry 1 JOHNSON MICHAEL · CIK 0001311173 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 407,830 Underlying: Common Stock · 244,698 shares Expires 2025-03-02 F1 · kind: On March 2, 2015, the reporting person was granted an award of 407,830 stock appreciation rights ("SARs"). The amount and timing of the vesting of these SARs is dependent upon the achievement by Herbalife Ltd. (the "Company") of certain performance criteria for each of fiscal 2015, 2016 and 2017. The performance criteria for 2017 was met, resulting in 244,698 SARs which will vest on March 2, 2018. Read SEC document |
| December 11, 2017 Filed Dec 13, 2017 21:16 UTC | HERBALIFE LTD. HLF · Entity 4842 | Exercise / conversionStock Appreciation Right · Derivative | 327,868 | $0.00 Strike: $44.79 | $0.00 |
DisclosureSEC source: 0001209191-17-065420 · doc4.xml · derivative · entry 14 JOHNSON MICHAEL · CIK 0001311173 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 327,868 shares Expires 2022-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 11, 2017 Filed Dec 13, 2017 21:16 UTC | HERBALIFE LTD. HLF · Entity 4842 | Exercise / conversionStock Appreciation Right · Derivative | 210,648 | $0.00 Strike: $53.29 | $0.00 |
DisclosureSEC source: 0001209191-17-065420 · doc4.xml · derivative · entry 13 JOHNSON MICHAEL · CIK 0001311173 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 210,648 shares Expires 2021-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 11, 2017 Filed Dec 13, 2017 21:16 UTC | HERBALIFE LTD. HLF · Entity 4842 | Exercise / conversionStock Appreciation Right · Derivative | 132,416 | $0.00 Strike: $22.94 | $0.00 |
DisclosureSEC source: 0001209191-17-065420 · doc4.xml · derivative · entry 12 JOHNSON MICHAEL · CIK 0001311173 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 132,416 shares Expires 2020-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 11, 2017 Filed Dec 13, 2017 21:16 UTC | HERBALIFE LTD. HLF · Entity 4842 | Tax withholdingCommon Stock | 64,924 | $69.81 | $4,532,344.44 |
DisclosureSEC source: 0001209191-17-065420 · doc4.xml · nonDerivative · entry 9 JOHNSON MICHAEL · CIK 0001311173 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,062,957 F3 · kind: The reporting person received 52,584 shares of common stock upon the net exercise of 327,868 SARS. The reporting person forfeited 210,360 shares of common stock underlying such SARS in payment of the exercise price and 64,924 shares of common stock underlying such SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on December 11, 2017 of $69.81. Read SEC document |
| December 11, 2017 Filed Dec 13, 2017 21:16 UTC | HERBALIFE LTD. HLF · Entity 4842 | Disposition to issuerCommon Stock | 210,360 | $69.81 | $14,685,231.60 |
DisclosureSEC source: 0001209191-17-065420 · doc4.xml · nonDerivative · entry 8 JOHNSON MICHAEL · CIK 0001311173 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,127,881 F3 · kind: The reporting person received 52,584 shares of common stock upon the net exercise of 327,868 SARS. The reporting person forfeited 210,360 shares of common stock underlying such SARS in payment of the exercise price and 64,924 shares of common stock underlying such SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on December 11, 2017 of $69.81. Read SEC document |
| December 11, 2017 Filed Dec 13, 2017 21:16 UTC | HERBALIFE LTD. HLF · Entity 4842 | Exercise / conversionCommon Stock | 327,868 | $44.79 | $14,685,207.72 |
DisclosureSEC source: 0001209191-17-065420 · doc4.xml · nonDerivative · entry 7 JOHNSON MICHAEL · CIK 0001311173 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,338,241 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 11, 2017 Filed Dec 13, 2017 21:16 UTC | HERBALIFE LTD. HLF · Entity 4842 | Tax withholdingCommon Stock | 27,542 | $69.81 | $1,922,707.02 |
DisclosureSEC source: 0001209191-17-065420 · doc4.xml · nonDerivative · entry 6 JOHNSON MICHAEL · CIK 0001311173 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,010,373 F2 · kind: The reporting person received 22,306 shares of common stock upon the net exercise of 210,648 SARS. The reporting person forfeited 160,800 shares of common stock underlying such SARS in payment of the exercise price and 27,542 shares of common stock underlying such SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on December 11, 2017 of $69.81. Read SEC document |
| December 11, 2017 Filed Dec 13, 2017 21:16 UTC | HERBALIFE LTD. HLF · Entity 4842 | Disposition to issuerCommon Stock | 160,800 | $69.81 | $11,225,448.00 |
DisclosureSEC source: 0001209191-17-065420 · doc4.xml · nonDerivative · entry 5 JOHNSON MICHAEL · CIK 0001311173 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,037,915 F2 · kind: The reporting person received 22,306 shares of common stock upon the net exercise of 210,648 SARS. The reporting person forfeited 160,800 shares of common stock underlying such SARS in payment of the exercise price and 27,542 shares of common stock underlying such SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on December 11, 2017 of $69.81. Read SEC document |
| December 11, 2017 Filed Dec 13, 2017 21:16 UTC | HERBALIFE LTD. HLF · Entity 4842 | Exercise / conversionCommon Stock | 210,648 | $53.29 | $11,225,431.92 |
DisclosureSEC source: 0001209191-17-065420 · doc4.xml · nonDerivative · entry 4 JOHNSON MICHAEL · CIK 0001311173 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,198,715 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 11, 2017 Filed Dec 13, 2017 21:16 UTC | HERBALIFE LTD. HLF · Entity 4842 | Tax withholdingCommon Stock | 49,120 | $69.81 | $3,429,067.20 |
DisclosureSEC source: 0001209191-17-065420 · doc4.xml · nonDerivative · entry 3 JOHNSON MICHAEL · CIK 0001311173 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,988,067 F1 · kind: The reporting person received 39,783 shares of common stock upon the net exercise of 132,416 stock appreciation rights ("SARS"). The reporting person forfeited 43,513 shares of common stock underlying such SARS in payment of the exercise price and 49,120 shares of common stock underlying such SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on December 11, 2017 of $69.81. Read SEC document |
| December 11, 2017 Filed Dec 13, 2017 21:16 UTC | HERBALIFE LTD. HLF · Entity 4842 | Disposition to issuerCommon Stock | 43,513 | $69.81 | $3,037,642.53 |
DisclosureSEC source: 0001209191-17-065420 · doc4.xml · nonDerivative · entry 2 JOHNSON MICHAEL · CIK 0001311173 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,037,187 F1 · kind: The reporting person received 39,783 shares of common stock upon the net exercise of 132,416 stock appreciation rights ("SARS"). The reporting person forfeited 43,513 shares of common stock underlying such SARS in payment of the exercise price and 49,120 shares of common stock underlying such SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on December 11, 2017 of $69.81. Read SEC document |
| December 11, 2017 Filed Dec 13, 2017 21:16 UTC | HERBALIFE LTD. HLF · Entity 4842 | Exercise / conversionCommon Stock | 132,416 | $22.94 | $3,037,623.04 |
DisclosureSEC source: 0001209191-17-065420 · doc4.xml · nonDerivative · entry 1 JOHNSON MICHAEL · CIK 0001311173 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,080,700 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 17, 2017 Filed May 19, 2017 20:32 UTC | HERBALIFE LTD. HLF · Entity 4842 | Exercise / conversionStock Appreciation Right · Derivative | 250,000 | $0.00 Strike: $6.82 | $0.00 |
DisclosureSEC source: 0001209191-17-033945 · doc4.xml · derivative · entry 14 JOHNSON MICHAEL · CIK 0001311173 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 250,000 shares Expires 2019-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 17, 2017 Filed May 19, 2017 20:32 UTC | HERBALIFE LTD. HLF · Entity 4842 | Exercise / conversionStock Appreciation Right · Derivative | 240,000 | $0.00 Strike: $6.82 | $0.00 |
DisclosureSEC source: 0001209191-17-033945 · doc4.xml · derivative · entry 13 JOHNSON MICHAEL · CIK 0001311173 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 240,000 shares Expires 2019-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.